The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

Chalasani, Naga; M. Younossi, Zobair; E. Lavine, Joel; Charlton, Michael; Cusi, Kenneth; E. Rinella, Mary; A. Harrison, Stephen; M. Brunt, Elizabeth; J. Sanyal, Arun

doi:10.1002/hep.29367

Public

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

Published in Hepatology • Jul 17, 2017

Authors:

Naga Chalasani

Zobair M. Younossi

Joel E. Lavine

Abstract

Potential conflict of interest: Dr. Chalasani consults for and received grants from Eli Lilly. He consults for NuSirt, AbbVie, Afimmune, Tobira, Madrigal, Shire, Cempra, Ardelyx, Axovant, and Amarin. He received grants from Intercept, Gilead, Galectin, and Cumberland. Dr. Younossi consults for Brist...

Subject

Nonalcoholic fatty liver disease

Medicine

Internal medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!